Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Global Companion Animal Diagnostics Market Size, Share, and Forecast - 2033 | Market to Reach $6.7 Billion as Point-of-Care Innovation Drives 8.8% CAGR

globenewswire.com
IDXX IDEXX Laboratories is mentioned as a participant in the competitive companion animal diagnostics market, which is projected to grow significantly. The article does not provide specific sentiment towards IDEXX. ZTS Zoetis Inc. is listed as a competitor in the growing companion animal diagnostics market. The article does not offer specific sentiment or performance details for Zoetis. TMO Thermo Fisher Scientific Inc. is named as a player in the companion animal diagnostics sector. The article focuses on market trends and growth, without specific sentiment for Thermo Fisher. NEOG Neogen Corporation is mentioned as a participant in the companion animal diagnostics market, which is expected to grow. The article does not provide specific sentiment for Neogen.

Global Companion Animal Diagnostics Market Size, Share, and Forecast - 2033 | Market to Reach $6.7 Billion as Point-of-Care Innovation Drives 8.8% CAGR Dublin, Oct. 14, 2026 (GLOBE NEWSWIRE) -- "Companion Animal Diagnostics Market Insights, Competitive Landscape, and Market Forecast - 2033" has been added to ResearchAndMarkets.com's offering.

The global companion animal diagnostics market is projected to grow from USD 3.7 billion in 2026 to USD 6.7 billion by 2033, registering a CAGR of 8.8% during the forecast period. According to the report, increasing pet ownership, greater awareness of animal health, rising disease prevalence, and continued innovation in veterinary diagnostic technologies are supporting sustained market expansion.

Market Overview

Companion animals are increasingly viewed as integral household members, strengthening demand for preventive veterinary care, early disease detection, and treatment monitoring. Veterinary clinics, hospitals, and diagnostic laboratories are expanding their use of instruments, consumables, immunodiagnostics, molecular diagnostics, hematology systems, and other advanced testing solutions for dogs, cats, and additional domestic animals.

The growing incidence of chronic conditions, infectious diseases, parasitic infestations, and lifestyle-related disorders is increasing the need for accurate and timely testing. At the same time, veterinary healthcare providers are investing in diagnostic infrastructure to improve access to sophisticated solutions. These developments are expected to increase testing volumes and create long-term opportunities for manufacturers and service providers.

Key Companion Animal Diagnostics Market Drivers

Business Opportunities

Emerging markets across Asia-Pacific, Latin America, and the Middle East offer significant expansion potential as pet populations grow and veterinary infrastructure improves. Companies developing portable point-of-care platforms and lab-on-chip technologies are also positioned to benefit from demand for rapid, reliable testing in clinics and decentralized care settings.

Strategic collaborations among diagnostic manufacturers, veterinary hospitals, distributors, and research organizations can support product development and accelerate commercial adoption. Additional opportunities include breed-specific and condition-specific diagnostics, digital veterinary platforms, online pet health services, and e-commerce distribution channels.

Regional Market Analysis

Competitive Landscape

The market remains highly competitive, with participants prioritizing product innovation, geographic expansion, distribution agreements, and strategic partnerships. Companies identified in the report include IDEXX Laboratories, Inc., Zoetis Inc., Heska Corporation, Thermo Fisher Scientific Inc., Virbac, Bayer Animal Health, Neogen Corporation, Fujifilm Holdings Corporation, Indical Bioscience GmbH, Idvet, Randax Laboratories, Bionote Inc., Skyla Corporation, Urit Medical Electronic Co., Ltd., Nova Biomedical, Swissavans AG, Alvedia, Megacor Veterinary Diagnostics, Biopanda Reagents Ltd., Anipoc Ltd., and Ring Biotechnology Co Ltd.

Market Segmentation

The report indicates that continued investment in veterinary diagnostics, increased spending on companion animal healthcare, and demand for faster testing will shape market development through 2033. Businesses offering scalable, accurate, and accessible diagnostic solutions are expected to be well-positioned to capture emerging opportunities across established and developing markets.

For more information about this report visit https://www.researchandmarkets.com/r/nk1sek

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.